BRP Recalling Thousands of Snowmobiles Due to Safety Risk
By Robb M. Stewart
The parent company of Ski-Doo is recalling thousands of snowmobiles in the U.S. and Canada because of the risk a ski could break and cause a crash and serious injury, the U.S. safety watchdog said.
The Consumer Product Safety Commission in a notice said the safety recall involves all of BRP's 2024 Ski-Doo MXZ and Renegade snowmobiles equipment with "Pilot X" skis. The recall covers about 8,100 of the snowmobiles in the U.S., and about 5,600 that were sold in Canada.
The commission said owners should immediately stop using the vehicles and contract BRP to schedule a free inspection and for a no-cost replacement of the left ski at a dealership.
The Canadian company in late January wrote to Ski-Doo owners advising them of the safety recall. It said the left Pilot X skis may break due to a molding process issue at the supplier.
While the fix should take less than an hour to complete, BRP said a limited number of parts were available in Canada and the U.S. In other countries, parts were set to be available from Feb. 8, it said.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
February 29, 2024 11:42 ET (16:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track